======= URI1 ======= == Gene Information == * **Official Symbol**: URI1 * **Official Name**: URI1 prefoldin like chaperone * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8725|8725]] * **UniProt**: [[https://www.uniprot.org/uniprot/O94763|O94763]] * **Interactions**: [[https://thebiogrid.org/search.php?search=URI1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20URI1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603494|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes member of the prefoldin family of molecular chaperones. The encoded protein functions as a scaffolding protein and plays roles in ubiquitination and transcription, in part though interactions with the RNA polymerase II subunit RPB5. This gene may play a role in multiple malignancies including ovarian cancer and hepatocellular carcinoma. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 22. [provided by RefSeq, Nov 2011]. * **UniProt Summary**: Involved in gene transcription regulation. Acts as a transcriptional repressor in concert with the corepressor UXT to regulate androgen receptor (AR) transcription. May act as a tumor suppressor to repress AR-mediated gene transcription and to inhibit anchorage-independent growth in prostate cancer cells. Required for cell survival in ovarian cancer cells. Together with UXT, associates with chromatin to the NKX3-1 promoter region. Antagonizes transcriptional modulation via hepatitis B virus X protein. |Prefoldin| |phosphatase inhibitor activity| |RNA polymerase II complex binding| |protein phosphatase inhibitor activity| |phosphoprotein binding| |negative regulation of phosphoprotein phosphatase activity| |negative regulation of protein dephosphorylation| |negative regulation of intrinsic apoptotic signaling pathway| |negative regulation of phosphatase activity| |negative regulation of dephosphorylation| |regulation of phosphoprotein phosphatase activity| |regulation of protein dephosphorylation| |regulation of intrinsic apoptotic signaling pathway| |regulation of phosphatase activity| |cellular response to steroid hormone stimulus| |regulation of dephosphorylation| |negative regulation of apoptotic signaling pathway| |transcription corepressor activity| |response to virus| |response to steroid hormone| |chromatin binding| |regulation of apoptotic signaling pathway| |regulation of cell growth| |dendrite| |negative regulation of hydrolase activity| |cellular response to growth factor stimulus| |negative regulation of intracellular signal transduction| |cellular response to lipid| |response to growth factor| |cellular response to organic cyclic compound| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |cellular response to hormone stimulus| |regulation of growth| |negative regulation of catalytic activity| |response to lipid| |negative regulation of transcription by RNA polymerase II| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |response to hormone| |response to organic cyclic compound| |negative regulation of cell death| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |mitochondrion| |negative regulation of signal transduction| |regulation of hydrolase activity| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |negative regulation of biosynthetic process| |regulation of programmed cell death| |negative regulation of response to stimulus| |regulation of cell death| |negative regulation of gene expression| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-3.13| |[[:results:exp392|PT-1 25μM R07 exp392]]|-2.23| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|-2.06| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|-1.99| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|-1.93| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.92| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.8| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-1.74| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-1.74| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|-1.73| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|1.8| |[[:results:exp145|PNU96415E 10μM R03 exp145]]|1.86| |[[:results:exp83|Trametinib 10μM R02 exp83]]|1.94| |[[:results:exp225|Celastrol 0.12μM R05 exp225]]|2.07| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|2.14| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 546/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|24/28| |blood|22/28| |bone|22/25| |breast|27/33| |central nervous system|37/56| |cervix|4/4| |colorectal|11/17| |esophagus|13/13| |fibroblast|1/1| |gastric|12/15| |kidney|11/21| |liver|12/20| |lung|57/75| |lymphocyte|11/14| |ovary|23/26| |pancreas|21/24| |peripheral nervous system|13/16| |plasma cell|13/15| |prostate|1/1| |skin|18/24| |soft tissue|2/7| |thyroid|1/2| |upper aerodigestive|18/22| |urinary tract|23/29| |uterus|4/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3727 * **Expression level (log2 read counts)**: 6.04 {{:chemogenomics:nalm6 dist.png?nolink |}}